Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention
FH Europe Foundation shared an insightful post from Professor Zanfina Ademi on LinkedIn:
“Lp(a): A Missed Opportunity in Cardiovascular Prevention
Despite its strong genetic link to ASCVD and its prevalence in 1 in 5 people, Lp(a) raemains under-tested in clinical practice. A new study in Atherosclerosis highlights both the clinical relevance and cost-effectiveness of routine Lp(a) testing, strengthening the case for its integration into cardiovascular risk assessment.
Led by Monash University, supported by global experts and initiated by FH Europe Foundation, the study shows:
- Routine Lp(a) testing is cost-saving across multiple health systems
- It enables earlier intervention with existing therapies
- It supports value-based care and equitable access to precision prevention
The findings align with the Brussels International Declaration, a 2025 global policy initiative urging governments to include Lp(a) in national cardiovascular screening programs.
Prof. Zanfina Ademi, senior author and health economist at Monash: “From both a public health and economic standpoint, this is a highly cost-effective intervention targeting a major gap in cardiovascular prevention.”
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 17:20Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
-
Dec 16, 2025, 17:14Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions
-
Dec 16, 2025, 17:06Davood KHoda Amorzideh on VTE and Bleeding in Cancer
-
Dec 16, 2025, 16:56Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
-
Dec 16, 2025, 16:50Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story